Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 7Pain, Postoperative 3Ovarian Neoplasms 3Brain Neoplasms 3Stomach Neoplasms 2Pain 2Neoplasms 2Fallopian Tube Neoplasms 2Breast Neoplasms 2Warts 1Urinary Bladder Neoplasms 1Stroke 1Sepsis 1Schwannomatosis 1Prostatic Neoplasms 1Pleural Effusion 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Pancreatic Cyst 1Neuroinflammatory Diseases 1Neurilemmoma 1Neoplasm Metastasis 1Multiple Myeloma 1Metastatic Non-Squamous Non-Small Cell Lung Cancer 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hypoxia 1Hyperthermia 1Hemorrhage 1

Interventions

Tadalafil 1Surveys and Questionnaires 1Saline Solution 1Educational Status 1Androgen Antagonists 1Ambulatory Care Facilities 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Erectile Dysfunction × Saline Solution × 90 days × Clear all
NCT07048314 2026-03-19

Stem Cells for Erectile Dysfunction Post RALP

The Methodist Hospital Research Institute

Phase 1/2 Not yet recruiting
40 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡